Immuno 2026 Day 2 Highlights: Unraveling the Tumor Microenvironment and New Paths to Overcome Immunotherapy Resistance
Sep 25, 2026
View online
Immuno 2026 Day 2 Highlights: Unraveling the Tumor Microenvironment and New Paths to Overcome Immunotherapy Resistance
FDA Approved Belzutifan Plus Lenvatinib in Advanced ccRCC
Rare Cells, Big Stories: What Circulating Tumor Cells Can Tell Us About Cancer
WCC 2026 Highlights the Human Crisis in Cancer Care Through a Lancet Oncology Commission Discussion
Vincent Rajkumar: What Do the First Randomized Etentamig Data Mean for Myeloma?
FDA Grants Priority Review to Perioperative Durvalumab Plus Neoadjuvant Enfortumab Vedotin for Muscle-Invasive Bladder Cancer
Steve Jobs, Apple, and Cancer: The True Story Behind His Rare Diagnosis
100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond
NIH PRIMED-AI Validation Center 2026
Pancreatic Cancer Action Network Collaborative Catalyst Research Award 2027
The 21st Meeting of the EANO 2026
Australian and New Zealand Society of Palliative Medicine Conference (ANZSPM 2026)
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
